Depression Clinical Trials in San Antonio

Showing 61-80 of 164 trials

Mentors Offering Maternal Support (M-O-M-S™): A Prenatal Program for Decreasing Maternal Anxiety and Depression

NCT03393637

The M-O-M-S project evaluates the effectiveness of the M-O-M-S program for improving birth outcomes and maternal-infant attachment and role satisfaction in a large military sample.

Anxiety FearPrenatal DepressionInfant, Low Birth Weight+2 more

University of the Incarnate Word1,717 participantsStarted Dec 2017

San Diego, California, United States • San Antonio, Texas, United States • Tacoma, Washington, United States

COMPLETEDPhase 2/3< 1 mile

A Clinical Trial of PRAX-114 in Participants With Major Depressive Disorder

NCT04832425

This is a randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of PRAX-114 in participants with moderate to severe major depressive disorder (MDD). Participants will be randomized to receive 28 days of either 40 mg PRAX-114 or placebo in a 1:1 ratio.

Major Depressive Disorder

Praxis Precision Medicines216 participantsStarted Mar 2021

Phoenix, Arizona, United States • Garden Grove, California, United States • Lafayette, California, United States +28 more locations

Mentors Offering Maternal Support (M-O-M-S™): A Prenatal Program for Decreasing Maternal Anxiety and Depression

A Clinical Trial of PRAX-114 in Participants With Major Depressive Disorder

Depression Trials in Other Cities

SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)

Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an Antidepressant

A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder

Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)

IMPAACT 2002: Cognitive Behavioral Therapy and Medication Management for Treatment of Depression in US Youth With HIV

Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)

Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder

A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)

A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Assessing Symptomatic Clinical Episodes in Depression

A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder

Other Conditions in San Antonio